BAILEY DON M 4
4 · Lineage Cell Therapeutics, Inc. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
BAILEY DON M
Director
Transactions
- Purchase
Common Shares, no par value
2024-02-08$1.04/sh+96,155$100,001→ 158,801 total(indirect: By Trust)
Footnotes (1)
- [F1]Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.